Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2013. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial performance data.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details specific share movements for Sir Andrew Witty and a connected person:
- Sir Andrew Witty: On May 13, 2013, 686 Ordinary Shares were transferred from his holding, and 679 Ordinary Shares were repurchased into an ISA at prices of 1683.072p and 1683.8727p respectively. Additionally, 500 Ordinary Shares were gifted to each of his two children.
- Connected Person: On May 15, 2013, 677 Ordinary Shares were transferred from a nominee holding, and 670 Ordinary Shares were repurchased into an ISA at prices of 1706.1364p and 1707.1364p respectively.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The report is strictly a compliance notification under Disclosure Rule 3.1.4R(1)(a) and (c).
Investor Verification Points
- Verify the total shareholding balance of Sir Andrew Witty and the connected person following these transactions.
- Confirm the pricing of the ISA repurchases against the market price on the transaction dates.
- Note that this filing contains no operational or financial performance updates for the period.